Clin2
NCT07869199Possibly a fitNot yet recruiting

Hair loss and gut health: a nutritional drink study

Gut DysbiosisTelogen EffluviumHair Loss

Part of Skin clinical trials.

This study looks at whether a daily drinkable supplement can help women with hair loss (telogen effluvium) that has lasted more than 3 months. It also checks how the supplement affects the gut bacteria and the scalp, possibly improving hair growth.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 40 years
Study type
Observational

Who can take part

  • You are a woman between 18 and 40 years old.
  • You are still having regular periods (premenopausal).
  • You have been diagnosed with telogen effluvium (a common type of temporary hair loss) for more than 3 months.
  • You have some digestive discomfort (like bloating or irregular bowel habits) but no diagnosed digestive disease.
  • You have not used any anti-hair-loss products in the last 3 months.
  • You are not pregnant, breastfeeding, or within 6 months after giving birth.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07484061Recruiting
Drinkable supplement for hair loss in women on weight-loss drugs

This trial tests if a special drinkable supplement can help prevent or reduce hair loss in women who are taking a GLP-1 or GIP receptor agonist (a type of weight-loss or diabetes medication). The study looks for women who have just started this medication or have been on it for less than 3 months.

Madrid, Madrid
NCT07810504Recruiting
Laser and solution combo for female hair loss

This study tests a combination of a scalp solution and LED light therapy to treat androgenic alopecia (female pattern hair loss). The goal is to see if the two treatments together can help regrow hair and improve scalp health.

Pasadena, California
NCT06648850Not yet recruiting· Phase 2/Phase 3
Scalp treatment for reducing hair shedding and regrowing hair

This study tests a new scalp product called DA-001 to see if it reduces hair shedding and helps hair grow back in people with telogen effluvium. It's a clinical trial that compares the treatment to a placebo (a product without the active ingredient) to find out if it works.

NCT07862374Not yet recruiting
Oral minoxidil with or without a supplement for female hair loss

This study looks at how well a daily pill (oral minoxidil) works for mild female pattern hair loss, either by itself or combined with a drinkable supplement. It aims to see which approach improves hair growth and reduces shedding, and how it affects women's feelings about hair loss.

Madrid, Madrid
NCT07783113Not yet recruiting
Hair supplement for hair loss linked to weight-loss drugs

This study tests a dietary supplement to help women who are experiencing hair shedding (telogen effluvium) after using GLP-1 medications like semaglutide or tirzepatide for weight loss. It aims to see if the supplement can reduce hair loss and improve hair health.

São Paulo, São Paulo
NCT07835646Not yet recruiting
Hair supplement for stress-related hair loss

This trial tests a dietary supplement designed to reduce occasional hair shedding caused by stress, poor diet, pollution, or seasonal changes. If you've noticed more hair falling out than usual over the last few months, this study will see if the supplement helps improve your hair condition over 90 days.

Barcelona

Hear when a new Gut Dysbiosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.